Projects per year
Fingerprint
Dive into the research topics where Emmanuel Petricoin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Developing an algorithm for Molecular Tailored Therapy
Brody, J. J., Petricoin, E., Albanese, C., Madhavan, S. & Pishvaian, M. M.
Pancreatic Cancer Action Network, American Association for Cancer Research
1/01/15 → …
Project: Research
-
Developing an algorithm for Molecular Tailored Therapy
Brody, J. J., Petricoin, E., Pishvaian, M. M., Albanese, C. & Madhavan, S.
1/07/15 → 30/06/18
Project: Research
-
CGE25-106: MHC II More Effectively Predicts Response to Pembrolizumab Than PD-L1 in HER2 Negative Patients
Fogarty, E., Corgiat, B., Sparks, K., Arnell, C., Petricoin, E., Davis, J. & Mueller, C., 28 Mar 2025, In: JNCCN Journal of the National Comprehensive Cancer Network. 23, 35Research output: Contribution to journal › Article › peer-review
-
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database
Levi, A., Blais, E., Davelaar, J., Ebia, M. I., Minasyan, A., Nikravesh, N., Gresham, G., Zheng, L., Chuy, J. W., Shroff, R. T., Wadlow, R. C., DeArbeloa, P., Matrisian, L. M. C., Petricoin, E., Pishvaian, M. J., Gong, J., Hendifar, A. E. & Osipov, A., 1 Mar 2025, In: Oncologist. 30, 3, oyaf007.Research output: Contribution to journal › Article › peer-review
-
Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer
DeLiberty, J. M., Roach, M. K., Stalnecker, C. A., Robb, R., Schechter, E. G., Pieper, N. L., Taylor, K. E., Pita, L. M., Yang, R., Bang, S., Drizyte-Miller, K., Ackermann, S. E., Nicewarner Peña, S. R., Baldelli, E., Min, S. M., Drewry, D. H., Petricoin, E. F., Morris, J. P., Der, C. J., Cox, A. D., & 1 others, 15 Apr 2025, In: Cancer Research. 85, 8, p. 1479-1495 17 p.Research output: Contribution to journal › Article › peer-review
-
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment
Berezovsky, A., Nuga, O., Datta, I., Bergman, K., Sabedot, T., Gurdziel, K., Irtenkauf, S., Hasselbach, L., Meng, Y., Mueller, C., Petricoin, E. F., Brown, S., Purandare, N., Aras, S., Mikkelsen, T., Poisson, L., Noushmehr, H., Ruden, D. & Decarvalho, A. C., Feb 2025, In: PLoS ONE. 20, 2 February, e0315171.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards
Hunt, A. L., Randall, J., Mansukhani, M. M., Nyberg, K., Nutcharoen, A., Davis, J., Corgiat, B., Mueller, C., Melvin, S., Sharma, M., Johnston, L., Swain, W., Abulez, T., Bateman, N. W., Maxwell, G. L., Deeken, J., Benyounes, A., Petricoin, E. F., Cannon, T. L. & Conrads, T. P., Dec 2025, In: npj Precision Oncology. 9, 1, 111.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Reports on Precision Oncology Findings from Inova Health System Provide New Insights (Real-time functional proteomics enhances therapeutic targeting in precision oncology molecular tumor boards)
Nicholas Bateman, Thomas Conrads, Larry Maxwell & Emmanuel Petricoin
2/05/25
1 item of Media coverage
Press/Media
-